Activation of Peroxisome Proliferator-Activated Receptor-γ in Dendritic Cells Inhibits the Development of Eosinophilic Airway Inflammation in a Mouse Model of Asthma
✍ Scribed by Hamida Hammad; Hendrik Jan de Heer; Thomas Soullié; Véronique Angeli; François Trottein; Henk C. Hoogsteden; Bart N. Lambrecht
- Book ID
- 117021489
- Publisher
- American Society for Investigative Pathology
- Year
- 2004
- Tongue
- English
- Weight
- 712 KB
- Volume
- 164
- Category
- Article
- ISSN
- 0002-9440
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract BRL 49653 (rosiglitazone) is a thiazolidinedione anti‐diabetic drug that activates the nuclear receptor, peroxisome proliferator‐activated receptor gamma (PPARγ). Pilot clinical trials have shown evidence of therapeutic activity of PPARγ agonists against prostate cancer. To more effecti
## Abstract Asthma is a chronic disorder of the airways characterized by variable airway narrowing, mucus hypersecretion, and infiltration of the airway wall with eosinophils. It is now believed that asthma is controlled by Th2 lymphocytes producing cytokines such as IL‐4, IL‐5, IL‐9, and IL‐13. An